| 序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
| 1 |
586379-66-0 |
PH-797804 |
≥98% |
|
询价 |
| 2 |
745833-23-2 |
VX-702 |
≥98% |
|
询价 |
| 3 |
862507-23-1 |
Ralimetinib dimysylate(LY2228820 dimysylate) |
≥98% |
|
询价 |
| 4 |
152121-30-7 |
SB202190(FHPI) |
≥98% |
|
询价 |
| 5 |
285983-48-4 |
BIRB 796(Doramapimod) |
≥98% |
|
询价 |
| 6 |
152121-47-6 |
Adezmapimod(SB203580 RWJ-64809) |
≥98% |
|
询价 |
| 7 |
22862-76-6 |
Anisomycin(NSC-76712,AI 3-50846,Flagecidin,Wuningmeisu C) |
≥98% |
|
询价 |
| 8 |
1809784-29-9 |
DTP3 |
≥98% |
|
询价 |
| 9 |
312917-14-9 |
TCS JNK 5a |
≥98% |
|
询价 |
| 10 |
1410880-22-6 |
JNK-IN-8 |
≥98% |
|
询价 |
| 11 |
129-56-6 |
SP600125(SP600125 NSC75890) |
≥98% |
|
询价 |
| 12 |
869886-67-9 |
Ulixertinib(BVD-523 VRT752271) |
≥98% |
|
询价 |
| 13 |
181223-80-3 |
DEL-22379 |
≥98% |
|
询价 |
| 14 |
896720-20-0 |
VX-11e |
≥98% |
|
询价 |
| 15 |
1435488-37-1 |
XMD17-109 |
≥98% |
|
询价 |
| 16 |
1453848-26-4 |
Ravoxertinib(GDC-0994 RG-7842) |
≥98% |
|
询价 |
| 17 |
865362-74-9 |
FR 180204 |
≥98% |
|
询价 |
| 18 |
1234480-50-2 |
XMD8-92 |
≥98% |
|
询价 |
| 19 |
942183-80-4 |
SCH772984 |
≥98% |
|
询价 |
| 20 |
923032-37-5 |
Refametinib(RDEA119,BAY86-9766) |
≥98% |
|
询价 |
| 21 |
391210-00-7 |
PD318088 |
≥98% |
|
询价 |
| 22 |
1035555-63-5 |
TAK-733 |
≥98% |
|
询价 |
| 23 |
869357-68-6 |
AZD8330(ARRY704 ARRY424704) |
≥98% |
|
询价 |
| 24 |
334949-59-6 |
BIX 02188 |
≥98% |
|
询价 |
| 25 |
305350-87-2 |
SL-327 |
≥98% |
|
询价 |
| 26 |
957054-30-7 |
GDC-0941(Pictilisib) |
|
5mg, 10mg, 50mg, 200mg |
询价 |
| 27 |
252917-06-9 |
CHIR-99021 |
|
2mg, 5mg, 10mg, 50mg, 100mg |
询价 |
| 28 |
1236699-92-5 |
Pimasertib(SAR245509,AS703026,MSC1936369B) |
≥98% |
|
询价 |
| 29 |
606143-89-9 |
Binimetinib(Mektovi ARRY438162 ARRY162 MEK162) |
≥98% |
|
询价 |
| 30 |
934660-93-2 |
Cobimetinib(GDC-0973,RG-7420,XL-518) |
≥98% |
|
询价 |
| 31 |
1168091-68-6 |
GDC-0623(G-868) |
≥98% |
|
询价 |
| 32 |
1094614-85-3 |
BIX 02189 |
≥98% |
|
询价 |
| 33 |
|
NR-160 |
≥98% |
|
询价 |
| 34 |
942487-16-3 |
PF-03814735 |
≥98% |
|
询价 |
| 35 |
945595-80-2 |
AMG-900 |
≥98% |
|
询价 |
| 36 |
693228-63-6 |
CYC116 |
≥98% |
|
询价 |
| 37 |
934353-76-1 |
ENMD-2076 |
≥98% |
|
询价 |
| 38 |
934541-31-8 |
TAK-901 |
≥98% |
|
询价 |
| 39 |
422513-13-1 |
Hesperadin |
≥98% |
|
询价 |
| 40 |
398493-79-3 |
PHA-680632 |
≥98% |
|
询价 |
| 41 |
942947-93-5 |
CCT129202 |
≥98% |
|
询价 |
| 42 |
1158838-45-9 |
TCS7010(Aurora A Inhibitor I) |
≥98% |
|
询价 |
| 43 |
1010085-13-8 |
MK-5108(VX689) |
≥98% |
|
询价 |
| 44 |
5142-23-4 |
3-Methyladenine(3-MA) |
|
25mg, 50mg, 100mg, 200mg, 500mg |
询价 |
| 45 |
1095382-05-0 |
CCT137690 |
≥98% |
|
询价 |
| 46 |
85622-93-1 |
Temozolomide(TMZ) |
|
10mg, 50mg, 100mg, 500mg |
询价 |
| 47 |
616-91-1 |
Acetylcysteine(NAC) |
|
500mg |
询价 |
| 48 |
243984-11-4 |
TAK-242(Resatorvid) |
|
5mg, 10mg, 25mg |
询价 |
| 49 |
942918-07-2 |
GSK1070916(NMI900 or GSK1070916 A) |
≥98% |
|
询价 |
| 50 |
15663-27-1 |
Cisplatin |
|
100mg, 500mg |
询价 |
| 51 |
443797-96-4 |
JNJ-7706621 |
≥98% |
|
询价 |
| 52 |
1000669-72-6 |
KW-2449 |
≥98% |
|
询价 |
| 53 |
885325-71-3 |
MK-8745 |
≥98% |
|
询价 |
| 54 |
1207293-36-4 |
BI-847325 |
≥98% |
|
询价 |
| 55 |
827318-97-8 |
Danusertib(PHA739358) |
≥98% |
|
询价 |
| 56 |
477600-75-2 |
Tofacitinib |
|
5mg, 10mg, 50mg, 100mg |
询价 |
| 57 |
869363-13-3 |
MLN8054 |
≥98% |
|
询价 |
| 58 |
331771-20-1 |
ZM 447439 |
≥98% |
|
询价 |
| 59 |
722544-51-6 |
Barasertib(INH-34 AZD-1152-HQPA) |
≥98% |
|
询价 |
| 60 |
639089-54-6 |
Tozasertib(VX680 MK0457) |
≥98% |
|
询价 |
m.cnreagent.com
